Related references
Note: Only part of the references are listed.Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine
Longding Liu et al.
PLOS ONE (2013)
A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine
Aristine Cheng et al.
VACCINE (2013)
Development of a Vero cell DNA reference standard for residual DNA measurement in China
Shouchun Cao et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71
Qunying Mao et al.
ARCHIVES OF VIROLOGY (2012)
Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
Ai-Hsiang Chou et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Analysis of the Th1/Th2 Reaction in the Immune Response Induced by EV71 Inactivated Vaccine in Neonatal Rhesus Monkeys
Yan Liang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
Ai-Hsiang Chou et al.
PLOS ONE (2012)
Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
Qunying Mao et al.
PLOS ONE (2012)
Reactogenicity and Immunogenicity of an Enterovirus 71 Vaccine in Chinese Healthy Children and Infants
Feng-Cai Zhu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Selection and characterization of vaccine strain for Enterovirus 71 vaccine development
Jui-Yuan Chang et al.
VACCINE (2012)
Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial
Yan-Ping Li et al.
VACCINE (2012)
The effect of enterovirus 71 immunization on neuropathogenesis and protein expression profiles in the thalamus of infected rhesus neonates
Huicheng Chen et al.
VIROLOGY (2012)
Production of EV71 vaccine candidates
Pele Chong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children An open label, phase 1 clinical trial
Fan-Yue Meng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Challenges to Licensure of Enterovirus 71 Vaccines
Min-Shi Lee et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process
Chia-Chyi Liu et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System
Chia-Chyi Liu et al.
PLOS ONE (2011)
The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008
Xiaojuan Tan et al.
PLOS ONE (2011)
Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection
Emily Jane Bek et al.
VACCINE (2011)
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
Zhenglun Liang et al.
VACCINE (2011)
Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys
Chenghong Dong et al.
VACCINE (2011)
Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection
Longding Liu et al.
VIROLOGY (2011)
Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys
Chenghong Dong et al.
HUMAN VACCINES (2010)
Enterovirus 71 vaccine: close but still far
Dingmei Zhang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71
Tom Solomon et al.
LANCET INFECTIOUS DISEASES (2010)
Combined peptides of human enterovirus 71 protect against virus infection in mice
Jiang Ning Liu et al.
VACCINE (2010)
Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield
Cheng-Yu Chung et al.
VACCINE (2010)
EV71: An emerging infectious disease vaccine target in the Far East?
Juan Xu et al.
VACCINE (2010)
Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal, challenge
Yao-Chi Chung et al.
VACCINE (2008)
Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide
Damian Guang Wei Foo et al.
MICROBES AND INFECTION (2007)
An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys
Minetaro Arita et al.
JOURNAL OF VIROLOGY (2007)
High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture
Chia-Chyi Liu et al.
VACCINE (2007)
Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71
Cheng-Hsun Chiu et al.
MICROBES AND INFECTION (2006)
Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development
SC Wu et al.
VACCINE (2004)
Characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate
YC Lin et al.
VACCINE (2002)
Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus
CN Wu et al.
VACCINE (2001)
Share Paper
